S Korean biotech firm Orum Therapeutics raises $30m in Series B round

S Korean biotech firm Orum Therapeutics raises $30m in Series B round

Photo by Louis Reed on Unsplash

Orum Therapeutics, a South Korean biotech company, has raised $30 million in a Series B financing round to advance cell-penetrating, cell-specific antibody technology for novel therapeutics, according to an announcement.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter